Mativ
Manufactures filtration media, advanced films, tapes, liners, specialty paper, packaging, and healthcare materials.
Something off on this page? Send us feedback.
Profile
Sells engineered specialty materials through Filtration & Advanced Materials and Sustainable & Adhesive Solutions, spanning filtration media, films, netting, tapes, liners, specialty papers, packaging, and healthcare. The United States is the largest geography, international sales remain material, and demand depends on cycle-exposed end markets plus manufacturing execution.
Manufactures specialty materials through Filtration & Advanced Materials and Sustainable & Adhesive Solutions. Product families include filtration media, advanced films, netting, tapes, labels, release liners, specialty paper, packaging, and healthcare materials sold through a family of product brands.
The United States is the largest geography, Europe is the next largest region, and international sales remain material. After selling Engineered Papers, the portfolio no longer participates in tobacco-based product markets.
Execution relies on coating, converting, polymer film, fiber, resin, saturation, lamination, embossing, and customer-specific process know-how. The business depends on cycle-exposed end markets, manufacturing reliability, labor agreements across parts of the workforce, and completion of the post-merger portfolio and cost reset.
Company facts
Categories
Key statistics
Year to date +2.6% · Average volume (30d) 592.4K
Analysts
No analyst consensus on record.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026Q2 FY26 | $0.28 | $0.50 | +78.6% | $508.5M | $531.8M | +4.6% | +22.05% |
| May 6, 2026Q1 FY26 | $0.02 | $0.06 | +200.0% | $486.9M | $188.3M | −61.3% | +1.18% |
| Feb 18, 2026Q4 FY25 | $0.09 | $0.15 | +66.7% | $469.5M | $463.1M | −1.4% | −7.96% |
| Nov 5, 2025Q3 FY25 | $0.27 | $0.39 | +44.4% | $469.6M | $513.7M | +9.4% | +21.94% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $484.8M | $525.4M | $513.7M | $463.1M | $479.6M | $531.8M | |
| Gross profit | $72.6M | $103.7M | $99.4M | $71.3M | $68.9M | $113.3M | |
| Operating income | −$430.6M | $20.1M | $16.0M | $11.8M | $8.6M | $35.3M | |
| Net income | −$425.5M | −$9.5M | −$3.2M | $100.8M | −$11.7M | $3.6M | |
| Diluted EPS | −$7.82 | −$0.18 | −$0.06 | $1.80 | −$0.21 | $0.06 | |
| Gross margin | 15.0% | 19.7% | 19.3% | 15.4% | 14.4% | 21.3% | |
| Operating margin | -88.8% | 3.8% | 3.1% | 2.5% | 1.8% | 6.6% |
Fiscal years (4-quarter sums)FY21 $1.44B · FY22 $2.04B · FY23 $2.03B · FY24 $1.98B · FY25 $1.99B
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $66.3M · Total debt $1.03B · Total assets $1.99B · Shareholders' equity $470.7M
Dividends
Last cut to $0.10 from $0.40 in Aug 2023. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 28, 2026 | Aug 28 | Sep 25 | $0.10 | |
| May 29, 2026 | May 29 | Jun 19 | $0.10 | |
| Mar 13, 2026 | Mar 13 | Mar 27 | $0.10 | |
| Nov 28, 2025 | Nov 28 | Dec 19 | $0.10 | |
| Aug 29, 2025 | Aug 29 | Sep 26 | $0.10 | |
| May 23, 2025 | May 23 | Jun 27 | $0.10 | |
| Mar 14, 2025 | Mar 14 | Mar 28 | $0.10 | |
| Nov 29, 2024 | Nov 29 | Dec 20 | $0.10 |
Ownership
Shares outstanding 55.12M · Float 49.96M · 90.7% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 6.21M | 11.26% | 13F | Aug 7, 2026 |
| Rubric Capital Management LP | 3.98M | 7.23% | 13F | Aug 14, 2026 |
| Allspring Global Investments Holdings, LLC | 3.73M | 6.77% | 13F | Aug 13, 2026 |
| American Century Companies Inc | 3.09M | 5.60% | 13F | Aug 12, 2026 |
| Stowers Institute for Medical Research | 3.09M | 5.60% | 13G | Aug 14, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
View detailsPeers
- Avery Dennison
Pressure-sensitive labels, release stacks, and medical tapes
- 3M
Industrial tapes, films, filtration, and consumer materials
- Donaldson
Filtration media and components across industrial and life science uses
- Amcor
Flexible and healthcare packaging with material-science scale
- Magnera
Nonwovens for healthcare, hygiene, wipes, food, and filtration
- Tredegar
Surface-protection and advanced packaging films
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Mativ | $12.07 | −0.49% | $668.6M | 7.6 | 12.8 | 0.3 | +1.2% |
| Avery Dennison | $176.75 | −0.53% | $13.60B | 19.5 | 17.0 | 1.5 | +10.9% |
| 3M | $174.82 | +0.27% | $89.91B | 31.0 | 18.8 | 3.6 | +2.5% |
| Donaldson | $91.89 | −0.01% | $10.65B | 23.9 | 21.0 | 2.7 | +8.0% |
| Amcor | $46.80 | +0.28% | $21.58B | 19.6 | 10.7 | 0.9 | +25.9% |
| Magnera | $12.40 | +0.16% | $441.4M | — | 10.5 | 0.1 | +7.7% |
| Tredegar | $7.80 | +0.13% | $272.2M | 8.1 | — | 0.3 | +20.7% |
| Median | 19.6 | 17.0 | 1.2 | +9.4% |